ZeroTo510 is a Memphis-based medical technology program that supports early-stage founders looking to accelerate toward commercialization. The program includes equity investment and a 13-week curriculum focused on regulatory and quality dynamics.

ZeroTo510

ZeroTo510 | 1,074 followers on LinkedIn. Accelerating MedTech Innovation in Memphis, TN | ZeroTo510 is a Memphis-based medical technology program that supports early-stage founders looking to accelerate toward commercialization. We specialize in supporting innovative startups in the medical technology industry, offering $25k in seed money and a highly competitive 90-day acceleration intensive cohort. Our program provides comprehensive support, including mentorship, initial investment, and collaboration with dedicated peers.

Helping the next generation of entrepreneurs mold raw ideas into great companies

Olaf Schulz

President & CEO at Phoenix Kinetics

Ryan Belaney

Market Access, Reimbursement and Value-Based Commercialization Strategy Executive

Erik Harris

Product Development/Project Management

Stewart Young

🎉 A tremendous thank you to Erin Dorgan for sharing her expertise on brand awareness and SEO optimization with the ZeroTo510 cohort! Erin led an insightful session on the importance of the marketing funnel, building a brand "universe" to effectively connect with key audiences, and optimizing content to improve visibility and reach. Plus, Erin has been collaborating with Epicenter on refining our LinkedIn strategy to better connect with our medical innovation community. Thanks for sharing your knowledge! #BrandAwareness #Innovation #SEO #ZeroTo510 #EpicenterMemphis #StartupEcosystem #MedicalDevice

Kickstart your morning with Epicenter and Tennessee Small Business Development Centers (TSBDC) as we dive into how our partnership is fostering innovative entrepreneurship in Memphis! ☀️ From free business consulting to powerful resources for growth, learn how we’re teaming up to fuel your business success. Don’t miss this chance to connect, learn, and grow with our community! 🔗 Register now: https://lu.ma/ct649fiw #EpicenterMemphis #TSBDC #MemphisEntrepreneurs #BusinessGrowth #MemphisInnovation

Epicenter Memphis

🎉 Huge congratulations to Idicula M. and the Hera Health Solutions team on this incredible milestone! As a graduate of #ZeroTo510 , Idicula is continuing to push boundaries with groundbreaking innovations. This exclusive licensing deal with Geovista not only scales their bioerodible technology but also paves the way for better veterinary treatments worldwide. 🌎🐾 We’re thrilled to see their success and look forward to what’s next! 🚀 #ZeroTo510 #HeraHealth #Innovation #AnimalHealth #StartupSuccess #MemphisProud

Huge thanks to Lia Winter and Preston Dishner from Winter Innovations for leading an insightful Lunch & Learn session with the ZeroTo510 cohort! 🛠️ They shared valuable tips on building effective sales engines, streamlining processes, and finding quality leads. Their journey and expertise are inspiring for entrepreneurs looking to scale smartly. #SalesStrategy #StartupGrowth #ZeroTo510 #EpicenterMemphis #MedTechInnovation

At ZeroTo510, every milestone matters—whether it's your first prototype, securing a 510(k), or hitting $100K in sales. These steps aren’t just checkboxes—they increase your company’s value and pave the way for market success. 🚀 Customer discovery is key to building the right product for the right problem. And when it comes to regulatory approval, data-backed claims ensure smooth navigation through the FDA process. Our advice? Plan early, iterate often, and stay focused on meaningful milestones. Success is more than just launch—it’s about sustainable growth. #ZeroTo510 #MedTechInnovation #MemphisInnovation #AcceleratingMedTechInnovation #EpicenterMemphis #CustomerDiscovery

I am excited and grateful to be part of this ZeroTo510 cohort and in the presence of such innovative companies and resilient founders. Corami Biotech is founded based on Dr. Rebecca Levit 's ideas that will fundamentally change how the heart is treated. We spend over $30bn on drugs for heart disease in the US alone and yet it remains #1 killer, anywhere. Heart is a challenging organ to systemically target due to its small size and receiving small amount of blood. There is a need to better target the heart whether it is for the delivery of known drugs with off-target issues or nextgen therapeutics. I am grateful to join Corami's incredibly experienced team to work on the clinical translation of this cardiac therapeutic platform. I am glad to have this opportunity to pursue my own mission to make a difference in patients' lives. More to come about Corami, our team, and our platform in the upcoming months, years... Please contact me if you would like to learn more. #cardiacgenetherapy #corami #patientsfirst

Esra Roan, PhD

Stop by Epicenter for a bite to eat on October 22 👀🌭🥩

"Speed means nothing if you don’t know where you’re going or how you’re going to get there." - our CEO, Shaherah Yancy, presenting to the ZeroTo510 2024 Cohort of startups on approaching #regulatory paths with market success in mind. Startups are RLS's lifeblood, and several of our team members give their time to mentor #startups .

Research Lifecycle Solutions

The #ZeroTo510 cohort had an insightful session on "Breaking Down the 510(k)" led by Ryan Belaney , where we explored what it takes to navigate the FDA 's regulatory pathway for medical devices. Topics covered included substantial equivalence, the use of predicate devices, other submission types like investigational device exemptions and breakthrough device designations, and the importance of having a surgeon/m.d. to champion your idea. #MedTech #510k #FDARegulations #Startups #MedicalDevices #EpicenterMemphis

news impact assignment basic	general
public peers	general	Nov 12, 2024 8:01 AM	b903ab53
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Nov 12, 2024 8:01 AM	423e9f77
crunchbase trigger	general	Nov 12, 2024 8:01 AM	23802902
crunchbase profile	general
li profile	general	Nov 12, 2024 8:01 AM	1d5b2ba0
translate crunchbase fundingrounds	general
peers	general	Nov 12, 2024 8:01 AM	a252ff69
news basic	general	Nov 12, 2024 8:01 AM	5f1790e2
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

ZERO

COM:ZEROTO510

ZeroTo510